Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
22 December 2024
| Name: | ACUVAX LIMITED (ACU) (This company subsequently changed its name and is now PLUS CONNECT LIMITED. You should refer to that name for Status.) | |||||||||||||||
| Date of Listing: | 25 August 1971 | |||||||||||||||
| Subsequent Names: |
| |||||||||||||||
| Former Names: |
|
Stock Exchange Status:
This company subsequently changed its name and is now PLUS CONNECT LIMITED. You should refer to that name for Stock Exchange Status.Legal Status:
This company subsequently changed its name and is now PLUS CONNECT LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status:
This company subsequently changed its name and is now PLUS CONNECT LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| PLUS CONNECT LIMITED | 09/05/2018 | |
| ACTIVISTIC LIMITED | 13/05/2015 | 09/05/2018 |
| ACUVAX LIMITED | 05/12/2008 | 13/05/2015 |
| AVANTOGEN LIMITED | 31/05/2005 | 05/12/2008 |
| AUSTRALIAN CANCER TECHNOLOGY LIMITED | 04/05/2001 | 31/05/2005 |
| EXODUS MINERALS LIMITED | 14/08/1997 | 04/05/2001 |
| MINERALS MINING AND METALLURGY LIMITED | 14/08/1997 |
REGISTRY:
Security Transfer Australia Pty Ltd
No longer operating
The securities of Activistic Limited (the "Company") will be reinstated to official quotation as from 10 am EDST on 15 May 2015, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules. 86,338,988 ordinary shares fully paid Security Code ACU | 13/05/2015 |
name changed to Activistic Limited | 13/05/2015 |
issues a supplementary prospectus | 15/04/2015 |
releases an amended prospectus timetable | 08/04/2015 |
lodges a prospectus for an offer of 40,000,000 Shares at an issue price of $0.10 each to raise $4,000,000 before costs with provision for oversubscriptions of up to an additional 20,000,000 Shares at the same issue price to raise up to a maximum of $6,000,000 before costs | 26/03/2015 |
the 1 for 10 securities consolidation has now been finalised. | 20/03/2015 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 19/03/2015 |
The securities of Acuvax Limited (the "Company") will be suspended from official quotation prior to the commencement of trading on Thursday 12 March 2015, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU | 12/03/2015 |
The suspension of trading in the securities of Acuvax Limited (the "Company") will be lifted from the commencement of trading tomorrow, Tuesday, 26 August 2014, following receipt of an announcement regarding completion of a capital raising. Security Code: ACU | 25/08/2014 |
resolutions considered at the general meeting were passed unanimously on a show of hands | 30/07/2014 |
a General Meeting of the Company will be held at Suite 4, 16 Ord Street West Perth, Western Australia on 30 July 2014 at 10:00AM (WST) | 01/07/2014 |
releases to the market a copy of the Company's corporate presentation that will be delivered to investors and their brokers during the upcoming investor presentations | 24/06/2014 |
company has executed a binding heads of agreement to acquire 100 % of all rights and title in all the issued capital Activistic Pty Ltd | 23/06/2014 |
confirms terms for a placement to sophisticated and professional investors to raise up to $600,000. Up to 1,200,000,000 shares will be placed to investors at an issue price of $0.0005 per share to raise a total of $600,000 | 20/06/2014 |
The ASX has made enquiries of the Company in that it has asked of the Company: ï‚· to provide a market update as to its status; ï‚· the plans the Company may have for trading in its securities to resume; and ï‚· the Company's progress in implementing those plans In response the Company has advised the market that Acuvax has appointed Mr Alex Bajada to its board of Directors | 30/05/2014 |
the results of the Annual General Meeting in accordance with listing rule 3.13.2 and section 251AA of the Corporations Act. - resolutions where passed unanimously on a show of hands | 27/11/2013 |
the Annual General Meeting of Shareholders of Acuvax Limited will be held at the Suite 4, 16 Ord Street, West Perth on Wednesday 27 th November 2013 commencing at 2:00 PM WST | 24/10/2013 |
releases Annual Report to shareholders | 27/09/2013 |
The Boards of Acuvax Ltd and Biolife Science Ltd are pleased to announce that the exposure period for the Acuvax Offer to raise up to $5m to fund Phase 2 trials of its HERVaxx cancer immunotherapy has now ended and that the Offer is now open. The Prospectus and Application Form are available on the Acuvax website at: www.acuvax.com.au | 04/04/2013 |
we understand that on or about this date the company consolidated its shares 1 for 200 | 22/03/2013 |
The securities of Acuvax Limited (the "Company") will be suspended from official quotation from the commencement of trading tomorrow, Friday 22 March 2013, pending the outcome of a resolution at the Company" general meeting to approve a change in the scale of the Company" activities. The Company" securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU | 21/03/2013 |
name changed from Avantogen Limited | 05/12/2008 |
The securities of Activistic Limited (the "Company") will be reinstated to official quotation as from 10 am EDST on 15 May 2015, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules. 86,338,988 ordinary shares fully paid Security Code ACU | 13/05/2015 |
name changed to Activistic Limited | 13/05/2015 |
issues a supplementary prospectus | 15/04/2015 |
releases an amended prospectus timetable | 08/04/2015 |
lodges a prospectus for an offer of 40,000,000 Shares at an issue price of $0.10 each to raise $4,000,000 before costs with provision for oversubscriptions of up to an additional 20,000,000 Shares at the same issue price to raise up to a maximum of $6,000,000 before costs | 26/03/2015 |
the 1 for 10 securities consolidation has now been finalised. | 20/03/2015 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 19/03/2015 |
The securities of Acuvax Limited (the "Company") will be suspended from official quotation prior to the commencement of trading on Thursday 12 March 2015, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU | 12/03/2015 |
The suspension of trading in the securities of Acuvax Limited (the "Company") will be lifted from the commencement of trading tomorrow, Tuesday, 26 August 2014, following receipt of an announcement regarding completion of a capital raising. Security Code: ACU | 25/08/2014 |
resolutions considered at the general meeting were passed unanimously on a show of hands | 30/07/2014 |
a General Meeting of the Company will be held at Suite 4, 16 Ord Street West Perth, Western Australia on 30 July 2014 at 10:00AM (WST) | 01/07/2014 |
releases to the market a copy of the Company's corporate presentation that will be delivered to investors and their brokers during the upcoming investor presentations | 24/06/2014 |
company has executed a binding heads of agreement to acquire 100 % of all rights and title in all the issued capital Activistic Pty Ltd | 23/06/2014 |
confirms terms for a placement to sophisticated and professional investors to raise up to $600,000. Up to 1,200,000,000 shares will be placed to investors at an issue price of $0.0005 per share to raise a total of $600,000 | 20/06/2014 |
The ASX has made enquiries of the Company in that it has asked of the Company: ï‚· to provide a market update as to its status; ï‚· the plans the Company may have for trading in its securities to resume; and ï‚· the Company's progress in implementing those plans In response the Company has advised the market that Acuvax has appointed Mr Alex Bajada to its board of Directors | 30/05/2014 |
the results of the Annual General Meeting in accordance with listing rule 3.13.2 and section 251AA of the Corporations Act. - resolutions where passed unanimously on a show of hands | 27/11/2013 |
the Annual General Meeting of Shareholders of Acuvax Limited will be held at the Suite 4, 16 Ord Street, West Perth on Wednesday 27 th November 2013 commencing at 2:00 PM WST | 24/10/2013 |
releases Annual Report to shareholders | 27/09/2013 |
The Boards of Acuvax Ltd and Biolife Science Ltd are pleased to announce that the exposure period for the Acuvax Offer to raise up to $5m to fund Phase 2 trials of its HERVaxx cancer immunotherapy has now ended and that the Offer is now open. The Prospectus and Application Form are available on the Acuvax website at: www.acuvax.com.au | 04/04/2013 |
we understand that on or about this date the company consolidated its shares 1 for 200 | 22/03/2013 |
The securities of Acuvax Limited (the "Company") will be suspended from official quotation from the commencement of trading tomorrow, Friday 22 March 2013, pending the outcome of a resolution at the Company" general meeting to approve a change in the scale of the Company" activities. The Company" securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. Security Code: ACU | 21/03/2013 |
name changed from Avantogen Limited | 05/12/2008 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Ian Murie | Non Exec Chairman | 21/10/2010 |
| Kevin Baum | Non Exec Director | 29/08/2014 |
| Roland Berzins | Director, Company Secretary | 27/01/2012 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Nigel Lee | Director | 17/10/2014 | 26/11/2014 |
| Alex Bajada | Non Exec Director | 23/05/2014 | 29/08/2014 |
| Anton Uvarov | Non Exec Director | 10/10/2013 | 14/03/2014 |
| Alistair Jobling | Director | 16/10/2012 | 10/10/2013 |
| Keong Chan | Director | 19/11/2010 | 15/10/2012 |
| Lloyd Flint | Director | 19/11/2010 | 27/01/2012 |
| William Ardrey | Chairman, CEO | 29/08/2006 | 08/02/2011 |
| Yvonne Foong | Director | 13/12/2006 | 19/11/2010 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
